Perindopril protects diabetics with coronary disease from cardiovascular death and heart attacks.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002423:Cause of Death; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000401:mortality; D005060:Europe; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality / Q000517:prevention & control; D020913:Perindopril / Q000627:therapeutic use*; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D020913:Perindopril